Effect of clozapine on motor function in schizophrenic patients

被引:0
|
作者
Vrtunski, PB [1 ]
Konicki, PE [1 ]
Kwon, KY [1 ]
Jaskiw, GJ [1 ]
Jaskiw, GE [1 ]
机构
[1] CASE WESTERN RESERVE UNIV, SCH MED, BRECKSVILLE, OH 44141 USA
关键词
schizophrenia; motor function impairment; force control; atypical antipsychotic drug; clozapine;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
It is well established that clozapine is less likely than typical antipsychotic drugs to cause clinically discernible extrapyramidal side-effects. There is a paucity of data, however, on clozapine's motor effects. In this report we compare normal controls to groups of chronic schizophrenic patients treated with either typical antipsychotic drugs or with clozapine. Motor function was measured with a target-matching task, a test relying on submaximal sustained force control. Results indicated that patients on clozapine performed with significantly lower accuracy (greater variability) of force control. Even though the clozapine patients were treatment resistant to typical antipsychotic drugs, and many had a history of tardive dyskinesia, we postulate that the observed deficit is likely due to clozapine treatment rather than to earlier treatments or other factors. The observed force control deficit may be the result of an increase in myoclonus and a generally lower level of overall motor activity.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 50 条
  • [1] Effect of clozapine on motor function in schizophrenic patients (vol 20, pg 187, 1996)
    Vrtunski, PB
    Konicki, PE
    Kwon, KY
    Jaskiw, GJ
    Jaskiw, GE
    SCHIZOPHRENIA RESEARCH, 1996, 22 (03) : 269 - 269
  • [2] SEROTONIN FUNCTION AND TREATMENT RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS
    KAHN, RS
    DAVIDSON, M
    SIEVER, L
    GABRIEL, S
    APTER, S
    DAVIS, KL
    AMERICAN JOURNAL OF PSYCHIATRY, 1993, 150 (09): : 1337 - 1342
  • [3] Heart rate variability in schizophrenic patients: Effect of clozapine
    Zimmermann, U
    Rechlin, T
    Kaschka, WP
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VA14 - VA14
  • [4] Quality of life of schizophrenic patients and clozapine
    Raoul, Y
    Manesse, P
    Delage, M
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1997, 23 : 12 - 16
  • [5] Clozapine effect on rCBF in patients with treatment-refractory schizophrenic patients.
    Ertugrul, A.
    Ergul-Lay, E.
    Basar, K.
    Volkan-Salanci, B.
    Demir, B.
    Ulug, B.
    Erbas, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S194 - S194
  • [6] Effect of clozapine on negative symptoms in schizophrenic patients with minimal positive symptoms
    Brar, JS
    Chengappa, KNR
    Sandman, AR
    Kreinbrook, SB
    Sheth, SA
    Ganguli, R
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 244 - 244
  • [7] Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis
    Yang, Xiding
    Yan, Qiangyong
    Yang, Lingfeng
    Li, Jingjing
    Fan, Xiao
    Chen, Jindong
    Wu, Haishan
    Yang, Yongyu
    Zhu, Ronghua
    Fang, Pingfei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (08) : 1181 - 1187
  • [8] Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients
    Chang, WH
    Lin, SK
    Lane, HY
    Wei, FC
    Hu, WH
    Lam, YWF
    Jann, MW
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (05): : 723 - 739
  • [9] DISPOSITION OF CLOZAPINE AND DESMETHYLCLOZAPINE IN SCHIZOPHRENIC-PATIENTS
    LIN, SK
    CHANG, WH
    LAM, FYW
    JANN, MW
    CHIEN, CP
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S118 - S118
  • [10] Pharmacokinetics and Pharmacogenetics of clozapine in Tunisian schizophrenic patients
    Chadli, Z.
    Ammar, H.
    Mhalla, A.
    Hannachi, I.
    Ben Romdhane, H.
    Ben Fadhl, N.
    Boughattas, N.
    Gaha, L.
    Chaabane, A.
    Ben Fredj, N.
    Aouam, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 74 - 74